Monitor for heart failure after breast-cancer chemotherapy: study

Attention drawn to trastuzumab and anthracyclines

Cardiac monitoring should be routine in breast cancer patients treated with certain chemotherapeutic agents, especially trastuzumab and anthracyclines, US researchers say.